- Clinical Trials
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,159GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,159GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,159GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,159GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,159GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1114EUR$1,250USD£966GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1114EUR$1,250USD£966GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1114EUR$1,250USD£966GBP
- Report
- May 2025
- 114 Pages
Global
From €4233EUR$4,750USD£3,671GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1782EUR$2,000USD£1,546GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1337EUR$1,500USD£1,159GBP
- Report
- June 2025
- 249 Pages
Global
From €3965EUR$4,450USD£3,439GBP
- Report
- February 2025
- 233 Pages
Global
From €2228EUR$2,500USD£1,932GBP
- Report
- January 2025
- 199 Pages
Global
From €2228EUR$2,500USD£1,932GBP
- Report
- May 2025
- 110 Pages
Global
From €4233EUR$4,750USD£3,671GBP
- Report
- December 2024
- 200 Pages
Global
From €3342EUR$3,750USD£2,898GBP
- Report
- April 2025
- 150 Pages
Global
From €2896EUR$3,250USD£2,512GBP
€4322EUR$4,850USD£3,748GBP
- Report
- March 2025
- 150 Pages
Global
From €2896EUR$3,250USD£2,512GBP
€4322EUR$4,850USD£3,748GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more